Carol O’Hear

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer

Leisha A. Emens, Cristina Cruz, Joseph P. Eder et al. · JAMA Oncology · 2018 · 774 citations · Full text

PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells

Wenting Zheng, Carol O’Hear, Rajshekhar Alli et al. · Leukemia · 2018 · 201 citations · Full text

Pi3k Orchestration, Signal Transduction, Immunology +8

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines

Stephen J. Schuster, Nancy L. Bartlett, Sarit Assouline et al. · Blood · 2019 · 179 citations

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study

Shirish M. Gadgeel, Rimas V. Lukas, Jerome H. Goldschmidt et al. · Lung Cancer · 2018 · 169 citations

Exploratory Analyses, Brain Metastases, Medicine +7

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study

David A. Sallman, Monzr M. Al Malki, Adam S. Asch et al. · Journal of Clinical Oncology · 2023 · 148 citations · Full text